BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4844058)

  • 21. [Cardiac output and central-hemodynamic parameter under bencyclan (author's transl)].
    Heidrich H; Paeprer H; Schneider B
    Z Kardiol; 1979 Jan; 68(1):53-6. PubMed ID: 419810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrokinetic charge and platelet aggreation. II. Correlation with platelet aggregation test.
    Migne J; Stoltz JF; Santonja R; Larcan A
    Acta Univ Carol Med Monogr; 1972; 53():59-64. PubMed ID: 4133936
    [No Abstract]   [Full Text] [Related]  

  • 23. [Blood rheology in chronic arterial occlusive disease as influenced by vasodilators (author's transl)].
    Störmer B; Kleinschmidt F; Loose D; Kremer K
    Dtsch Med Wochenschr; 1978 Apr; 103(16):694-8. PubMed ID: 639718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Oral therapy with bencyclane. Changes in blood-flow characteristics and spontaneous thrombocyte aggregation during oral therapy with bencyclane].
    Völker D
    ZFA (Stuttgart); 1979 Jan; 55(3):182-7. PubMed ID: 419814
    [No Abstract]   [Full Text] [Related]  

  • 25. Electrokinetic phenomena and platelet aggregation. I. Electrokinetic studies.
    Stolz JF; Migne J; Alexandre P; Santonja R; Streiff F; Larcan A
    Acta Univ Carol Med Monogr; 1972; 53():53-7. PubMed ID: 4133935
    [No Abstract]   [Full Text] [Related]  

  • 26. [Serum lipids following experimental fibrinolysis].
    Suschke J; Kunze D; von Pilar CE; Krejci K
    Monatsschr Kinderheilkd (1902); 1973 Jul; 121(7):388-9. PubMed ID: 4270871
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experimental platelet aggregation and arterial thrombosis. Effect of aspirin].
    Bousser MG; Lecrubier C
    Nouv Presse Med; 1973 Jun; 2(25):1687-92. PubMed ID: 4718537
    [No Abstract]   [Full Text] [Related]  

  • 28. [Inhibition of platelet function (mode of action of platelet inhibitors) (author's transl)].
    Baumgartner HR
    Ther Umsch; 1977 May; 34(5):341-6. PubMed ID: 867315
    [No Abstract]   [Full Text] [Related]  

  • 29. Rheological changes in the blood of patients with chronic arterial occlusive disease after the administration of vasoactive drugs.
    Störmer B; Kleinschmidt K; Loose D; Kremer K
    Curr Med Res Opin; 1977; 4(8):588-95. PubMed ID: 872611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inhibitory activity of bencyclan on platelet aggregation in vitro and in vivo (author's transl)].
    Jäger W; Scharrer I; Satkowski U; Breddin K
    Arzneimittelforschung; 1975; 25(12):1938-44. PubMed ID: 1243666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Measurement of thrombocyte adhesion in children (author's transl)].
    Suschke J; Stehr K; Jacobi E; Jurzik ML; Krejci K
    Klin Padiatr; 1973 Jul; 185(4):287-96. PubMed ID: 4542896
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of the effect of compound RA233 and bencyclane on platelet functions--with special reference to the effect on C-AMP metabolism.
    Ryo R
    Nihon Ketsueki Gakkai Zasshi; 1976 Feb; 39(1):97-108. PubMed ID: 183446
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cardiac side-effects of bencyclan].
    Köhler E; Motzer S; Noack E; Greeff K
    Dtsch Med Wochenschr; 1975 Feb; 100(9):427-9. PubMed ID: 234840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapy of arterial occlusive diseases. The effect of bencyclan in trained patients with peripheral arterial occlusive disease (Double-blind study)].
    Battke K; Buchwalsky R; Barmeyer J; Hoffmann G; Reindell H
    Fortschr Med; 1978 Jul; 96(26-27):1381-6. PubMed ID: 669532
    [No Abstract]   [Full Text] [Related]  

  • 35. [Thrombocyte function inhibition and anticoagulation in coronary, cerebral and peripheral arterial occlusive disease. 1. Pathogenesis, prevention, therapy].
    Marshall M
    Fortschr Med; 1982 Apr; 100(14):650-5. PubMed ID: 6979499
    [No Abstract]   [Full Text] [Related]  

  • 36. [In-vitro inhibition of thrombocyte aggregation induced by xenogenic serum].
    von Kaulla KN; Gerloff J
    Res Exp Med (Berl); 1972; 158(2):152-64. PubMed ID: 4116282
    [No Abstract]   [Full Text] [Related]  

  • 37. [From platelet functions to therapy].
    Jandrot-Perrus M; Nurden P
    Rev Med Interne; 2010 Dec; 31 Suppl 3():S319-23. PubMed ID: 21056518
    [No Abstract]   [Full Text] [Related]  

  • 38. [Platelet research method and its application in the study of "huo xuo hua yu"].
    Wang Z
    Zhong Xi Yi Jie He Za Zhi; 1984 Aug; 4(8):501-4. PubMed ID: 6238720
    [No Abstract]   [Full Text] [Related]  

  • 39. [The effect of bencyclan on shear induced platelet aggregation (author's transl)].
    Klose HJ; Rieger H; Schmid-Schönbein H
    Arzneimittelforschung; 1975 Jul; 25(7):1064-7. PubMed ID: 1174412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of experimental arterial thrombosis in dogs with platelet-deaggregating agents.
    Danese CA; Haimov M
    Surgery; 1971 Dec; 70(6):927-34. PubMed ID: 5124672
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.